NO993393D0 - Fotokjemoterapeutiske blandinger - Google Patents

Fotokjemoterapeutiske blandinger

Info

Publication number
NO993393D0
NO993393D0 NO993393A NO993393A NO993393D0 NO 993393 D0 NO993393 D0 NO 993393D0 NO 993393 A NO993393 A NO 993393A NO 993393 A NO993393 A NO 993393A NO 993393 D0 NO993393 D0 NO 993393D0
Authority
NO
Norway
Prior art keywords
same
therapy
optionally
therapeutic mixtures
photochemical therapeutic
Prior art date
Application number
NO993393A
Other languages
English (en)
Other versions
NO993393L (no
Inventor
Qian Peng
Jahn M Nesland
Karl Erik Giercksky
Johan Moan
Trond Warloe
Original Assignee
Photocure As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure As filed Critical Photocure As
Publication of NO993393D0 publication Critical patent/NO993393D0/no
Publication of NO993393L publication Critical patent/NO993393L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
  • Cosmetics (AREA)
  • Dental Preparations (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO993393A 1997-01-10 1999-07-09 Fotokjemoterapeutiske blandinger NO993393L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9700396.6A GB9700396D0 (en) 1997-01-10 1997-01-10 Photochemotherapeutic compositions
PCT/GB1998/000058 WO1998030242A2 (en) 1997-01-10 1998-01-09 Photochemotherapeutic compositions

Publications (2)

Publication Number Publication Date
NO993393D0 true NO993393D0 (no) 1999-07-09
NO993393L NO993393L (no) 1999-09-09

Family

ID=10805756

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993393A NO993393L (no) 1997-01-10 1999-07-09 Fotokjemoterapeutiske blandinger

Country Status (15)

Country Link
US (1) US6750212B2 (no)
EP (1) EP1015030A2 (no)
JP (1) JP2001501970A (no)
KR (1) KR20000070040A (no)
CN (1) CN1243445A (no)
AU (1) AU731042B2 (no)
BR (1) BR9807055A (no)
CA (1) CA2275659A1 (no)
GB (1) GB9700396D0 (no)
HU (1) HUP0000057A3 (no)
NO (1) NO993393L (no)
NZ (1) NZ336568A (no)
PL (1) PL334565A1 (no)
RU (1) RU2194532C2 (no)
WO (1) WO1998030242A2 (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6992107B1 (en) 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
DE19827417B4 (de) * 1998-06-19 2004-10-28 Hahn, Rainer, Dr.Med.Dent. Material zur unterschiedlichen Modifizierung der optischen Eigenschaften unterschiedlicher Zellen
JP3970492B2 (ja) * 1999-12-14 2007-09-05 コスモ石油株式会社 ピーリング用組成物
EP1997513B1 (en) * 2000-02-10 2012-04-11 Massachusetts Eye & Ear Infirmary Combinations and compositions for use in PDT in treating ocular conditions involving unwanted choriodal neovascularisation
DE10034673C1 (de) * 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
JP2004506005A (ja) * 2000-08-16 2004-02-26 ザ　ジェネラル　ホスピタル　コーポレイション　ディー　ビー　エイ　マサチューセッツ　ジェネラル　ホスピタル 尋常性挫瘡用の局所アミノレブリン酸−光力学的治療
GB0023367D0 (en) 2000-09-23 2000-11-08 Univ Leeds Photosensitisers
HU229805B1 (en) 2000-11-29 2014-07-28 Pci Biotech As Photochemical internalization for delivery of molecules into the cytosol
EP1339862B1 (en) 2000-11-29 2014-01-08 PCI Biotech AS Photochemical internalization for virus-mediated molecule delivery into the cytosol
RU2183956C1 (ru) * 2001-03-30 2002-06-27 Общество с ограниченной ответственностью "РАДА-ФАРМА" Фотосенсибилизатор и способ его получения
GB0121023D0 (en) 2001-08-30 2001-10-24 Norwegian Radium Hospital Res Compound
US20030100830A1 (en) * 2001-11-27 2003-05-29 Sheng-Ping Zhong Implantable or insertable medical devices visible under magnetic resonance imaging
RU2202339C1 (ru) * 2002-01-18 2003-04-20 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Средство для флюоресцентной диагностики
DE10202487A1 (de) 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermales Applikationssystem für Aminolävulinsäure-Derivate
RU2219921C1 (ru) * 2002-04-10 2003-12-27 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" Средство для флуоресцентной диагностики и фотодинамической терапии онкологических и неонкологических заболеваний
US7715901B2 (en) * 2002-05-08 2010-05-11 Yeda Research And Development Co. Ltd. Sensitized online BOLD-MRI imaging method
US20040186087A1 (en) * 2003-03-20 2004-09-23 Ceramoptec Industries, Inc. Siderophore conjugates of photoactive dyes for photodynamic therapy
DE10316566A1 (de) * 2003-04-10 2004-10-28 Haemato-Science Gmbh Mittel für die photodynamische Diagnostik und Therapie von bösartigen Tumoren
RU2286780C2 (ru) * 2004-09-30 2006-11-10 Государственный научный центр лазерной медицины Министерства здравоохранения РФ Способ лечения гнойных ран
GB0424833D0 (en) * 2004-11-10 2004-12-15 Photocure Asa Method
WO2006096492A2 (en) 2005-03-04 2006-09-14 Dusa Pharmaceuticals, Inc. Compositions and methods for reducing photosensitivity associated with photodynamic therapy
RU2329061C1 (ru) * 2006-10-23 2008-07-20 Петрозаводский государственный университет Нанокомпозитный фотосенсибилизатор для метода фотодинамического воздействия на клетки
GB0700580D0 (en) 2007-01-11 2007-02-21 Photocure Asa Use
KR100898394B1 (ko) * 2007-04-27 2009-05-21 삼성전자주식회사 반도체 집적 회로 장치 및 그 제조 방법
CA2724949A1 (en) 2007-06-27 2008-12-31 The General Hospital Corporation Method and apparatus for optical inhibition of photodynamic therapy
RU2347563C1 (ru) * 2007-11-21 2009-02-27 Государственное образовательное учреждение высшего профессионального образования "Саратовский государственный университет им. Н.Г. Чернышевского" Способ селективного разрушения меланомы
GB0724279D0 (en) * 2007-12-12 2008-01-23 Photocure Asa Use
RU2360711C1 (ru) * 2008-02-20 2009-07-10 Михаил Витальевич Мошнин Способ лечения угревой болезни
WO2011107478A1 (en) * 2010-03-01 2011-09-09 Photocure Asa Cosmetic compositions
WO2011122973A1 (ru) * 2010-04-01 2011-10-06 Хроматрикс Холдинг Лтд Изделие для использования в играх или тренировках и способ его эксплуатации
EP2657346B1 (en) 2010-12-24 2017-08-23 ARKRAY, Inc. Method for detecting cancer cell
JP5883889B2 (ja) * 2012-01-26 2016-03-15 Ｓｂｉファーマ株式会社 光線力学的診断剤、及び、フォトブリーチング防止剤
RU2511545C1 (ru) * 2013-02-07 2014-04-10 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" (ФГУП "ГНЦ "НИОПИК") Способ антимикробной фотодинамической терапии острых воспалительных заболеваний гортаноглотки или их гнойных осложнений
GB201306369D0 (en) * 2013-04-09 2013-05-22 Photocure As Irradiation device
RU2674025C1 (ru) * 2017-10-25 2018-12-04 Общество с ограниченной ответственностью "Научно-производственная фирма "ЭЛЕСТ" (ООО "НПФ "ЭЛЕСТ") Лекарственное средство на основе порфиринового фотосенсибилизатора копропорфирина для лечения рака кожи методом фотодинамической терапии
KR102621315B1 (ko) * 2020-09-25 2024-01-08 가톨릭대학교 산학협력단 의료기기 코팅용 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE360271B (no) 1970-09-07 1973-09-24 Bahco Ab
GB2058077B (en) 1979-06-08 1983-03-09 Szelke M Enkephalin analogues
CA1236029A (en) 1984-05-14 1988-05-03 Edmund Sandborn Pharmaceutical solutions comprising dimethyl sulfoxide
US4925736A (en) * 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
US5234940A (en) 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5079262A (en) 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
US5955490A (en) * 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US5422093A (en) 1989-07-28 1995-06-06 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
JP2767318B2 (ja) 1990-04-11 1998-06-18 株式会社コスモ総合研究所 ５―アミノレブリン酸アルキルエステル又はその塩及びその製造方法並びにこれを有効成分とする除草剤
AU655942B2 (en) 1990-10-05 1995-01-19 Queen's University At Kingston Porphyrin derivatives
US5219878A (en) 1990-10-05 1993-06-15 Queen's University Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
PL172480B1 (pl) * 1992-11-20 1997-09-30 Univ British Columbia Kompozycja do niszczenia lub uszkadzania obszaru nowego unaczynienia PL PL
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
NZ303251A (en) * 1995-03-10 2000-10-27 Photocure Asa Use of esters of 5-aminolevulinic acid as photosensitising agents in photochemotherapy
EP1187251A1 (en) 2000-09-01 2002-03-13 Marconi Commerce Systems S.r.L. Wireless communicaton interface

Also Published As

Publication number Publication date
AU5492698A (en) 1998-08-03
EP1015030A2 (en) 2000-07-05
NZ336568A (en) 2002-12-20
RU2194532C2 (ru) 2002-12-20
WO1998030242A3 (en) 1998-09-17
PL334565A1 (en) 2000-03-13
HUP0000057A3 (en) 2001-04-28
KR20000070040A (ko) 2000-11-25
CA2275659A1 (en) 1998-07-16
CN1243445A (zh) 2000-02-02
WO1998030242A2 (en) 1998-07-16
HUP0000057A2 (hu) 2000-10-28
AU731042B2 (en) 2001-03-22
NO993393L (no) 1999-09-09
BR9807055A (pt) 2000-05-02
US6750212B2 (en) 2004-06-15
JP2001501970A (ja) 2001-02-13
US20020061871A1 (en) 2002-05-23
GB9700396D0 (en) 1997-02-26

Similar Documents

Publication Publication Date Title
PL334565A1 (en) Phototherapeutic compositions
GB0018527D0 (en) Composition
BR9813524A (pt) Processos para tratamento de toxicidades associadas com a administração de um agente terapêutico a um mamìfero, para tratamento de toxicidades associadas com a exposição de um mamìfero à terapia de radiação, para tratamento de neuro- ou nefrodistúrbios em um humano, e, para tratamento de distúrbios e sintomas clìnicos associados com diabetes do tipo i ou do tipo ii em um humano
DE60035870D1 (de) Kombinationstherapie zur gewichtsreduzierung und fettleibigkeitsbehandlung
WO2004004661A3 (en) Boroproline compound combination therapy
WO2005063297A3 (en) Melatonin combination therapy for improving sleep quality
WO2005027842A8 (en) Combinations of drugs for the treatment of neoplasms
GB9710049D0 (en) Method
WO1996025947A3 (en) Induction of e-selectin for targetting therapeutic agents
IL182352A (en) Use of et-743 in the preparation of a medicament for treating cancer and medical kits containing et-743
WO2004006842A3 (en) Combinations of drugs for the treatment of neoplasms
MX9302038A (es) Metodo para el tratamiento del cancer por una terapia conjunta con derivados de 2-halometilideno y un agente antineoplasico especifico de fase m o fase s.
WO2005009342A3 (en) Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
BR0313117A (pt) Método para a produção de um efeito redutor de permeabilidade vascular e/ou antiangiogênico em um animal de sangue quente tal como um humano, método para o tratamento de um câncer em um animal de sangue quente tal como um humano, composição farmacêutica, kit, e, uso de zd6474 ou de um seu sal farmaceuticamente aceitável e de zd1839 ou de um seu sal farmaceuticamente aceitável
DE69400353D1 (de) Schlankmachende Zusammensetzung
IL141550A0 (en) Methods and compositions for the prevention or treatment of cancer
EP0671414A4 (en) ANTITHROMBOTIC.
DE60116075D1 (de) Behandlung von tumoren mit photodynamischer therapie
DE60301862D1 (de) Kombinationsbehandlung bei akutem myokardinfarkt
BRPI0412408A (pt) métodos para a produção de um efeito de redução antiangiogênico e/ou de permeabilidade vascular e para o tratamento de um cáncer em um animal de sangue quente tal como um ser humano, composição farmacêutica, kit, e uso de azd2171 ou um sal farmaceuticamente aceitável deste e zd1839 ou um sal farmaceuticamente aceitável deste
CY1106702T1 (el) Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων
WO2024097446A3 (en) Theranostic compounds targeting granzyme b
EP1234585A3 (en) Methods and compositions for the prevention or treatment of cancer
NO20010044D0 (no) Anvendelse av texapyriner i makrofag-medierte sykdommer
ID28035A (id) Kegunaan turunan antrasiklin untuk pengobatan tumor hati

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application